Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)

American Heart Journal

Volumn 167, Issue 5, 2014, Pages

  Rosenberg, Michael A ^a,b   Maziarz, Marlena ^c   Tan, Alex Y ^d   Glazer, Nicole L ^e   Zieman, Susan J ^f   Kizer, Jorge R ^g   Ix, Joachim H ^h   Djousse, Luc ⁱ   Siscovick, David S ^j   Heckbert, Susan R ^c   Mukamal, Kenneth J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; N TERMINAL PROPEPTIDE; PEPTIDE; PROCOLLAGEN; PROCOLLAGEN TYPE 3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART MUSCLE FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTICIPATORY RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UNITED STATES;

EID: 84899525953     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.01.010     Document Type: Article

References (45)

1. A.Y. Tan, and P. Zimetbaum Atrial fibrillation and atrial fibrosis J Cardiovasc Pharmacol 57 6 2011 625 629
2. E.P. Anyukhovsky, E.A. Sosunov, and A. Plotnikov et al. Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis Cardiovasc Res 54 2 2002 462 469
3. E.P. Anyukhovsky, E.A. Sosunov, and P. Chandra et al. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation Cardiovasc Res 66 2 2005 353 363
4. K. Ohtani, C. Yutani, and S. Nagata et al. High prevalence of atrial fibrosis in patients with dilated cardiomyopathy J Am Coll Cardiol 25 5 1995 1162 1169
5. T.J. Cha, J.R. Ehrlich, and L. Zhang et al. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure Circulation 109 3 2004 412 418
6. S. Verheule, E. Tuyls, and A. van Hunnik et al. Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation Circ Arrhythm Electrophysiol 3 6 2010 590 599
7. P.M. Kistler, P. Sanders, and M. Dodic et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation Eur Heart J 27 24 2006 3045 3056
8. M. Daccarett, T.J. Badger, and N. Akoum et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation J Am Coll Cardiol 57 7 2011 831 838
9. H. Sinno, K. Derakhchan, and D. Libersan et al. Atrial ischemia promotes atrial fibrillation in dogs Circulation 107 14 2003 1930 1936
10. J. Ausma, M. Wijffels, and F. Thone et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat Circulation 96 9 1997 3157 3163
11. S. Verheule, T. Sato, and Tt. Everett et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1 Circ Res 94 11 2004 1458 1465
12. P.G. Platonov, L.B. Mitrofanova, and V. Orshanskaya et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age J Am Coll Cardiol 58 21 2011 2225 2232
13. B. Burstein, and S. Nattel Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation J Am Coll Cardiol 51 8 2008 802 809
14. C. Mahnkopf, T.J. Badger, and N.S. Burgon et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation Heart Rhythm 7 10 2010 1475 1481
15. H.D. Xiao, S. Fuchs, and D.J. Campbell et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death Am J Pathol 165 3 2004 1019 1032
16. K. Friedrichs, A. Klinke, and S. Baldus Inflammatory pathways underlying atrial fibrillation Trends Mol Med 17 10 2011 556 563
17. S. Saba, A.M. Janczewski, and L.C. Baker et al. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha} Am J Physiol Heart Circ Physiol 289 4 2005 H1456 H1467
18. L.P. Fried, N.O. Borhani, and P. Enright et al. The Cardiovascular Health Study: design and rationale Ann Epidemiol 1 3 1991 263 276
19. B.M. Psaty, L.H. Kuller, and D. Bild et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study Ann Epidemiol 5 4 1995 270 277
20. M. Cushman, E.S. Cornell, and P.R. Howard et al. Laboratory methods and quality assurance in the Cardiovascular Health Study Clin Chem 41 2 1995 264 270
21. K.K. Patton, P.T. Ellinor, and S.R. Heckbert et al. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study Circulation 120 18 2009 1768 1774
22. P. Delanaye, E. Cavalier, and O. Moranne et al. Creatinine- or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease BMC Nephrol 14 1 2013 57
23. B.M. Psaty, T.A. Manolio, and L.H. Kuller et al. Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 7 1997 2455 2461
24. D. Mozaffarian, B.M. Psaty, and E.B. Rimm et al. Fish intake and risk of incident atrial fibrillation Circulation 110 4 2004 368 373
25. N.L. Glazer, E.M. Macy, and T. Lumley et al. Transforming growth factor beta-1 and incidence of heart failure in older adults: the Cardiovascular Health Study Cytokine 60 2 2012 341 345
26. E. Barasch, J.S. Gottdiener, and G. Aurigemma et al. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study Circ Heart Fail 2 4 2009 303 310
27. J. Risteli, S. Niemi, and P. Trivedi et al. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen Clin Chem 34 1988 715 718
28. R.S. Velagaleti, P. Gona, and J. Sundstrom et al. Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality Arterioscler Thromb Vasc Biol 30 11 2010 2283 2288
29. M. Cicoira, A. Rossi, and S. Bonapace et al. Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure J Card Fail 10 5 2004 403 411
30. H. Krum, M. Elsik, and H.G. Schneider et al. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy Circ Heart Fail 4 5 2011 561 568
31. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
32. M.A. Rosenberg, S. Das, and P.Q. Pinzon et al. A novel transgenic mouse model of cardiac hypertrophy and atrial fibrillation J Atr Fibrillation 2 9 2012 1 15
33. T. Koura, M. Hara, and S. Takeuchi et al. Anisotropic conduction properties in canine atria analyzed by high-resolution optical mapping: preferential direction of conduction block changes from longitudinal to transverse with increasing age Circulation 105 17 2002 2092 2098
34. D.D. Spragg, I. Khurram, and S.L. Zimmerman et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations Heart Rhythm 9 12 2012 2003 2009
35. S. de Jong, T.A. van Veen, and J.M. de Bakker et al. Biomarkers of myocardial fibrosis J Cardiovasc Pharmacol 57 5 2011 522 535
36. G. Krenning, E.M. Zeisberg, and R. Kalluri The origin of fibroblasts and mechanism of cardiac fibrosis J Cell Physiol 225 3 2010 631 637
37. S.K. Kim, H.N. Pak, and J.H. Park et al. Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion Europace 11 12 2009 1632 1638
38. S.K. Kim, J.H. Park, and J.Y. Kim et al. High plasma concentrations of transforming growth factor-beta and tissue inhibitor of metalloproteinase-1: potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation Circ J 75 3 2011 557 564
39. M. Kawamura, H. Ito, and T. Onuki et al. Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation J Cardiovasc Pharmacol 55 5 2010 511 517
40. M. Shimano, R. Shibata, and Y. Tsuji et al. Circulating adiponectin levels in patients with atrial fibrillation Circ J 72 7 2008 1120 1124
41. M. Behnes, U. Hoffmann, and S. Lang et al. Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure Clin Res Cardiol 100 4 2011 335 342
42. Y.K. On, E.S. Jeon, and S.Y. Lee et al. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure J Thorac Cardiovasc Surg 137 6 2009 1515 1520
43. M.R. Ki, D.G. Shin, and J.S. Park et al. Frequency of vacuolating cytotoxin A (VacA)-positive Helicobacter pylori seropositivity and TGF-beta1 decrease in atrial fibrillation Int J Cardiol 145 2 2010 345 346
44. E.M. Zeisberg, O. Tarnavski, and M. Zeisberg et al. Endothelial-to- mesenchymal transition contributes to cardiac fibrosis Nat Med 13 8 2007 952 961
45. J.S. Healey, S.J. Connolly, and M.R. Gold et al. Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2 2012 120 129